Inhibition of phytohaemagglutinin-induced lymphoproliferation by soluble annexin II in sera from patients with renal cell carcinoma

APMIS

Volumn 105, Issue 9, 1997, Pages 699-704

  Aarli, A ^a,c   Skeie Jensen, T ^b   Kristoffersen, E K ^a   Bakke, A ^b   Ulvestad, E ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c Armauer Hansen Building ^*  (Norway)

Author keywords

Annexin II; Clinical immunology; ELISA; Immunosuppressive factor; Immunosurveillance; Renal cell carcinoma

Indexed keywords

LIPOCORTIN 2; PHYTOHEMAGGLUTININ;

ARTICLE; CLINICAL IMMUNOLOGY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOSURVEILLANCE; KIDNEY CARCINOMA; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; SERUM;

EID: 9844242902     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1699-0463.1997.tb05073.x     Document Type: Article

References (26)

1. Aarli, Å., Matre, R. & Thunold, S.: IgG Fc receptors on epithelial cells of distal tubuli and on endothelial cells in human kidney. Int. Arch. Allergy Appl. Immunol. 557: 64-69, 1991.
2. Aarli, A., Skeie Jensen, T., Ulvestad, E. & Matre, R.: Suppression of mitogen-induced lymphoproliferation by soluble IgG Fc receptors in retroplacental serum in normal human pregnancy. Scand. J. Immunol. 37: 237-243, 1993.
3. Borowitz, M. J., Weiss, M. A., Bossen, E. H. & Metzgar, R. S.: Characterization of renal neoplasms with monoclonal antibodies to leukocyte differentiation antigens. Cancer 57: 251-256, 1986.
4. Cole, S. P. C., Pinkoski, M. J., Bhardwaj, G. & Deeley, R. G.: Elevated expression of annexin II (lipocortin II, p36) in a multidrug resistant small cell cancer line. Br. J. Cancer 65: 498-502, 1992.
5. Davis, R. G. & Vishwanatha, J. K.: Detection of secreted and intracellular annexin II by a radioimmunoassay. J. Immunol. Methods 188: 91-95, 1995.
6. Fridman, W. H., Sautès, C. & Teillaud, J. L.: Immunoglobulin-binding factors. Immunol. Lett. 20: 249-254, 1989.
7. Frohlich, M., Motté, P., Galvin, K., Takahashi, H., Wands, J. & Ozturk, M.: Enhanced expression of the protein tyrosine kinase substrate p36 in human hepatocellular carcinoma. Mol. Cell. Biol. 10: 3216-3223, 1990.
8. Kantor, A. F.: Current concepts in the epidemiology and etiology of primary renal cell carcinoma. J. Urol. 117: 415-417, 1977.
9. Katz, S. E. & Schapira, H. E.: Spontaneous regression of genitourinary cancer - an update. J. Urol. 128: 1-4, 1982.
10. Kristoffersen, E. K., Ulvestad, E., Bjorge, L., Aarli, Å. & Matre, R.: Fcγ-receptor activity of placental annexin II. Scand. J. Immunol. 40: 237-242, 1994.
11. Lê Thi Bich-Thuy & Revillard, J. P.: Selective suppression of human B lymphocyte differentiation into IgG-producing cells by soluble Fc receptors. J. Immunol. 129: 150-152, 1982.
12. Matre, R., Haaheim, L. R. & Tonder, O.: A monoclonal antibody inhibiting human placental Fcγ-receptor activity. Int. Arch. Allergy Appl. Immunol. 75: 227-229, 1984.
13. Matre, R., Kristoffersen, E. K., Ulvestad, E. & Vedeler, C. A.: Purification of a functional 40 kD human placental Fcγ-receptor using a monoclonal antibody. APMIS 97: 733-737, 1989.
14. McNichols, D. W., Segura, J. W. & DeWeerd, J. H.: Renal cell carcinoma: Long-term survival and late recurrence. J. Urol. 126: 17-23, 1981.
15. Muraki, J., Fischer, J., Addonizio, J. C., Nagamatsu, G. R. & Chiao, J. W.: Immunosuppressive factor derived from renal cancer cells. Urology 34: 205-209, 1989.
16. Pituch-Noworolska, A., Noworolski, J., Pryjma, J. & Zembala, M.: The role of shed Fc receptor in the regulation of lymphocyte response to phytohaemagglutinin (PHA). Immunology 55: 693-701, 1985.
17. Raynal, P. & Pollard, H. B.: Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipid-binding proteins. Biochim. Biophys. Acta 1197: 63-93, 1994.
18. Reeves, S. A., Chavez-Kappel, C., Davis, R., Rosenblum, M. & Israel, M. A.: Developmental regulation of annexin II (lipocortin 2) in human brain and expression in high grade glioma. Cancer Res. 52: 6871-6876, 1992.
19. Roseman, B. J., Bollen, A., Hsu, J., Lamborn, K. & Israel, M. A.: Annexin II marks astrocytic brain tumors of high histologic grade. Oncol. Res. 6: 561-567, 1994.
20. Schwartz-Albiez, R., Koretz, K., Möller, P. & Wirl, G.: Differential expression of annexins I and II in normal and malignant human mammary epithelial cells. Differentiation 52: 229-237, 1993.
21. Sulitzeanu, D.: Immunosuppressive factors in human cancer. Adv. Cancer Res. 60: 247-267, 1993.
22. Tressler, R. J., Updyke, T. V., Yeatman, T. & Nicolson, G. L.: Extracellular annexin II is associated with divalent cation-dependent tumor cell-endothelial cell adhesion of metastatic RAW117 large-cell lymphoma cells. J. Cell. Biochem. 53: 265-276, 1993.
23. Ulvestad, E., Kristoffersen, E. K., Skeie Jensen, T. & Matre, R.: Identification of a soluble Fcγ-binding molecule (annexin II) in human serum using a competitive ELISA. APMIS 102: 667-673, 1994.
24. Vishwanatha, J. K., Chiang, Y., Kumble, K. D., Hollingsworth, M. A. & Pour, P. M.: Enhanced expression of annexin II in human pancreatic carcinoma cells and primary pancreatic cancers. Carcinogenesis 14: 2575-2579, 1993.
25. Waisman, D. M.: Annexin II tetramer: structure and function. Mol. Cell. Biochem. 149/150: 301-322, 1995.
26. Yeatman, T. J., Updyke, T. V., Kaetzel M. A., Dedman, J. R. & Nícolson, G. L.: Expression of annexins on the surface of non-metastatic and metastatic human and rodent tumor cells. Clin. Exp. Metastasis 11: 37-44, 1993.